According to a study from York university the amount of prescription drugs in Italy have been reduced significantly after the introduction of CBD flower buds.
In June a four person medical board panel in Ohio will recommend some additions to the list of legal medical cannabis. Anxiety and autism spectrum disorder are the newcomers.
A former student from both universities have donated 9M USD to his alma maters- 4,5M to each of them- for cannabis research. The donor is the well known cannabis investor Charles R Broderick. Both MIT and Harvard assures that their research will not be affected by this fact.
According to a new American study cannabis can give MS patients considerable ease regarding symptoms and pain conditions.
In the wake of cannabis legalization pharmacists in the province of Ontario now have to undergo a mandatory cannabis course in order to keep practising.
Farmako is a German pharmaceutical company from Frankfurt. They just registered a patent that will make a modified tequila bacterium produce THC and CBD from sugar.
A recently published scientific study, “Joints for joints”, has, in somewhat cautious terms, stated that “cannabis could be an appropriate treatment for RA (rheumatoid arthritis).
In June 2018 DEA approved CBD in the form of Epidiolex, which is used for the treatment of seizures in children and adults. Thereby CBD got reclassified from Schedule 1 drug, which is an illegal substance, to a Schedule 5 “controlled substance”
Last year the Swedish medicinal company Enorama Pharma got permission from the Swedish Medical Products Agency to import and handle cannabis. They are now developing their medical cannabis chewing gum for the rapidly expanding global market.
Since cannabis still is illegal on the federal level in the US, many hospitals refuse to allow it. Instead they are treating terminally ill patients with opioids. The result is that these persons cannot communicate with their loved ones during their last hours alive.